Frontiers in Medicinal Chemistry

Volume 1


Atta-ur-Rahman, Allen B. Reitz

DOI: 10.2174/97816080520421040101
eISBN: 978-1-60805-204-2, 2004
ISBN: 978-1-60805-672-9
ISSN: 1567-2042 (Print)
ISSN: 1875-5763 (Online)

Recommend this eBook to your Library

Indexed in: Scopus, EMBASE, Chemical Abstracts, EBSCO, Ulrich's Periodicals Directory.

Frontiers in Medicinal Chemistry is a book series devoted to the review of area...[view complete introduction]

Table of Contents


- Pp. i

Atta-ur-Rahman, M. Iqbal Choudhary, Allen B. Reitz and Cheryl P. Kordik

Download Free

Targeting Protein Kinases for Bone Disease: Discovery and Development of Src Inhibitors

- Pp. 3-27 (25)

Chester A. Metcalf, Marie Rose van Schravendijk, David C. Dalgarno and Tomi K. Sawyer

View Abstract Download Free

Inhibitors of Matrix Metalloproteinases: Design, Structure and Therapeutic Applications

- Pp. 29-75 (47)

Jerry W. Skiles, Nina C. Gonnella and Arco Y. Jeng

View Abstract Download Free

Mechanism-based Inhibition of Metalloproteinases

- Pp. 77-83 (7)

Dong H. Kim and Shahriar Mobashery

View Abstract Purchase Chapter

Selective COX-2 Inhibitors and Dual Acting Anti-inflammatory Drugs: Critical Remarks

- Pp. 85-95 (11)

A. Bertolini, A. Ottani and M. Sandrini

View Abstract Purchase Chapter

Protein Farnesyltransferase Inhibitors

- Pp. 97-128 (32)

Semiramis Ayral-Kaloustian and Edward J. Salaski

View Abstract Purchase Chapter

The Design of Competitive, Small-molecule Inhibitors of Coagulation Factor Xa

- Pp. 129-152 (24)

Henry W. Pauls, William R. Ewing and Yong Mi Choi-Sledeski

View Abstract Purchase Chapter

Small Molecule Activators of the Insulin Receptor: Potential New Therapeutic Agents for the Treatment of Diabetes Mellitus

- Pp. 153-164 (12)

Edgardo Laborde and Vara Prasad Manchem

View Abstract Purchase Chapter

Current Therapies and Emerging Targets for the Treatment of Diabetes

- Pp. 165-187 (23)

Allan S. Wagman and John M. Nuss

View Abstract Purchase Chapter

Designed Enediyne Antitumor Agents

- Pp. 189-214 (26)

G.B. Jones and F.S. Fouad

View Abstract Purchase Chapter

Combinatorial Approaches in Anticancer Drug Discovery: Recent Advances in Design and Synthesis

- Pp. 215-235 (21)

Sukanta Bhattacharyya

View Abstract Purchase Chapter

The Expanding Role of NMR in Rational Drug Design

- Pp. 237-271 (35)

Rickey P. Hicks and Daniel A. Nichols

View Abstract Purchase Chapter

Mass Spectrometry Based Assays for Drug Screening in the Early Phases of Drug Discovery

- Pp. 273-292 (20)

Marshall M. Siegel

View Abstract Purchase Chapter

Recent Advances in PDE4 Inhibitors as Immunoregulators and Antiinflammatory Drugs

- Pp. 293-345 (53)

Catherine Burnouf, Ingrid Devillers and Marie-Pierre Pruniaux

View Abstract Purchase Chapter

Serotonin Reuptake Inhibition: An Update on Current Research Strategies

- Pp. 347-359 (13)

D. Spinks and G. Spinks

View Abstract Purchase Chapter

Emerging β-Amyloid Therapies for the Treatment of Alzheimer's Disease

- Pp. 361-384 (24)

Kelly A. Conway, Ellen W. Baxter, Kevin M. Felsenstein and Allen B. Reitz

View Abstract Purchase Chapter

Oxidative Stress in Animal Models of Accelerated Aging, Alzheimer’s Disease and Huntington’s Disease

- Pp. 385-397 (13)

D. Allan Butterfield

View Abstract Purchase Chapter

Constitutive Activity of Brain Serotonin Receptors: Inverse Agonist Activity of Antipsychotic Drugs

- Pp. 399-408 (10)

Anil Purohit, Katharine Herrick-Davis and Milt Teitler

View Abstract Purchase Chapter

Physicochemical Profiling (Solubility, Permeability and Charge State)

- Pp. 409-475 (67)

Alex Avdeef

View Abstract Purchase Chapter

Non-peptide Opioid Receptor Ligands - Recent Advances. Part I - Agonists

- Pp. 477-500 (24)

Agnieszka Kaczor and Dariusz Matosiuk

View Abstract Purchase Chapter

Nitric Oxide Therapies in Vascular Diseases

- Pp. 501-512 (12)

E.M. Kurowska

View Abstract Purchase Chapter

Strategies to Improve Stability and Bioavailability of Peptide Drugs

- Pp. 513-528 (16)

Céline Adessi and Claudio Soto

View Abstract Purchase Chapter

The Role of Genomics in the Discovery of Novel Antibacterial Targets

- Pp. 529-542 (14)

Jerry M. Buysse

View Abstract Purchase Chapter

New Anti-HIV Agents in Preclinical or Clinical Development

- Pp. 543-579 (37)

Erik De Clercq

View Abstract Purchase Chapter

DNA Minor Groove Alkylators

- Pp. 581-594 (14)

William A. Denny

View Abstract Purchase Chapter

Applications of Small Molecule Crystallography and the Cambridge Structural Database in Drug Design

- Pp. 595-606 (12)

Johan Wouters and Frédéric Ooms

View Abstract Purchase Chapter

Compound Optimization in Early and Late Phase Drug Discovery: Acceptable Pharmacokinetic Properties Utilizing Combined Physicochemical, In Vitro and In Vivo Screens

- Pp. 607-618 (12)

Gary W. Caldwell

View Abstract Purchase Chapter

DNA-binding of Drugs Used in Medicinal Therapies

- Pp. 619-645 (27)

G. Bischoff, S. Hoffmann and R. Zhdanov

View Abstract Purchase Chapter

The Contribution of Combinatorial Chemistry to Lead Generation: An Interim Analysis

- Pp. 647-662 (16)

Anton E.P. Adang and Pedro H.H. Hermkens

View Abstract Purchase Chapter

New Paradigms in Drug Design and Discovery

- Pp. 663-681 (19)

Joseph J. Barchi and Nouri Neamati

View Abstract Purchase Chapter

Author Index

- Pp. 683

Atta-ur-Rahman and Allen B. Reitz

Download Free

Subject Index

- Pp. 685-688 (4)

Atta-ur-Rahman and Allen B. Reitz

Download Free


Medicinal Chemistry has matured as a discipline, and there is no better time than the present to be a medicinal chemist. One of the primary driving forces in this renaissance is the increased value added by collaborations with biology, pharmacology, toxicology, spectroscopy, and allied fields earlier in the drug discovery process. The modern practicing medicinal chemist is inundated with new data, including in vitro and in vivo ADME profiling, which enables informed decisions that increase the likelihood of success in the future. This first issue of Frontiers in Medicinal Chemistry is being published only online, allowing for rapid and broad dissemination of the material presented. The chapters are selected from issues of Current Medicinal Chemistry, Current Topics in Medicinal Chemistry and Current Pharmaceutical Design to represent a cross-section of the most compelling subjects and developments in medicinal and bioorganic chemistry. The manuscripts and topics are clustered thematically, and overall constitute a substantial and impressive body of knowledge. The authors were given the opportunity to update their contributions, and many chose to do that. It is expected that Frontiers will be published on an annual basis in future years. Our thanks to Matthew Honan of Bentham Science Publishers for providing this opportunity.

Prof. Atta-ur-Rahman
Prof. M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi 75270

Allen B. Reitz, Ph.D.
Cheryl P. Kordik, Ph.D.
Johnson & Johnson Pharmaceutical
Research and Development
Spring House, Pennsylvania 19477

List of Contributors

Prof Atta-ur-Rahman FRS
University of Cambridge

Allen B. Reitz
Johnson & Johnson Pharmaceutical Research and Development
Spring House Pennsylvania

Associate Editor(s):
M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi, 75270

Cheryl P. Kordik
Johnson & Johnson Pharmaceutical Research and Development
Spring House, Pennsylvania

Editorial Advisory Board:
P.R Bernstein
University of Delaware

C. Bor-Luen
National Taiwan University

R. Efremov
M.M. Shemyakin & Yu.A. Ovchinnikov Institute of Bioorganic Chemistry

C. Garcia-Echeverria

D. Hadjipavlou-Litina
Arristotle Universith of Thessaloniki

D. Heymann
University of Nantes

D.A. Jans
Nuclear Signaling Laboratory, Monash University

G.B. Mahady
University of Illinois at Chicago

B. Malawska
Jagiellonian University Collegium Medicum

C. Philippe
Sciences and Technologies University of Lille


Webmaster Contact: Copyright © 2017 Bentham Science